|
Re: Contest
|
5
|
Resverlogix Corp.
|
Sep 16, 2019 12:57PM
|
|
Re: Kidney Week 2019 FR-PO317 From Barsax on another board
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 02:32PM
|
|
Re: We made it in Endpts news!
|
5
|
Resverlogix Corp.
|
Feb 03, 2020 02:03PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
5
|
Resverlogix Corp.
|
Sep 10, 2018 10:33AM
|
|
Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 02, 2019 11:59AM
|
|
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
|
5
|
Resverlogix Corp.
|
Jul 19, 2018 02:44PM
|
|
Re: Amgen cholesterol drug Repatha "Profound Regression", Dr. Nissen
|
5
|
Resverlogix Corp.
|
Nov 15, 2016 02:28PM
|
|
Re: I second that train of thought !!!
|
5
|
Resverlogix Corp.
|
Dec 01, 2015 05:43PM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 10:26AM
|
|
Re: Checklist for Management
|
5
|
Resverlogix Corp.
|
Jul 14, 2016 10:46AM
|
|
Re: Secondary endpoints
|
5
|
Resverlogix Corp.
|
Oct 22, 2019 09:34PM
|
|
Re: fda
|
5
|
Resverlogix Corp.
|
Nov 03, 2015 12:52PM
|
|
Resverlogix Announces Participation at the Upcoming GCFF Virtual Conference 2020 – Investing in Innovation
|
5
|
Resverlogix Corp.
|
Sep 08, 2020 10:50AM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
5
|
Resverlogix Corp.
|
Oct 07, 2019 10:09AM
|
|
An AHA or ASN Late Breaking Clinical Trial Presentation is possible
|
5
|
Resverlogix Corp.
|
Jun 19, 2018 01:21PM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:09PM
|
|
CANTOS and CIRT
|
5
|
Resverlogix Corp.
|
Nov 10, 2017 04:30PM
|
|
Re: New Share Price Contest
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 02:55PM
|
|
BIO-Europe Presentation
|
5
|
Zenith Epigenetics
|
Mar 13, 2018 12:09PM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:22PM
|
